Does surgery disseminate or accelerate cancer?

The Lancet

Volumn 346, Issue 8989, 1995, Pages 1506-1507

  Oliver, R T D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TISSUE INJURY;

EID: 0028807724     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92046-3     Document Type: Article

References (12)

1. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate: 23 year follow up of prospective randomised study
2. Changes in prostate cancer incidence and treatment in USA
3. On the cause of localisation of secondary tumour at points of injury
4. Preferential growth of blood borne cancer cells at site of trauma: a growth promoting role of macrophages
5. Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds
6. Carcinoma of the colon and rectum circulating malignant cells and five-year survival
7. Immunologically mediated restraint of latent tumour metastases
8. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy
9. Neoadjuvant androgen deprivation therapy prior to radical prostatectomy decreases PSM RT-PCR detected micrometastases
10. Effect of menstrual phase on surgical treatment of breast cancer
11. New directions with hormone therapy in prostate cancer possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy
12. Pregnancy and breast cancer